Carlsmed Stock (NASDAQ:CARL)
Previous Close
$12.29
52W Range
$8.50 - $17.19
50D Avg
$10.74
200D Avg
$12.08
Market Cap
$341.71M
Avg Vol (3M)
$168.78K
Beta
2.02
Div Yield
-
CARL Company Profile
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.